2022 annual financial data
Decoy Therapeutics 2022 Operating margin
Decoy Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -31,841,140 USD and net income was -31,607,956 USD.
Operating cash flow was -17,595,321 USD.
Get free Decoy Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -31,841,140 USD
- Net income
- -31,607,956 USD
- Operating cash flow
- -17,595,321 USD